When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PFE - Solid Bio down 59% premarket on another clinical hold on DMD gene therapy
Pfizer Inc.
Solid Biosciences (NASDAQ:SLDB) reports that the FDA has placed its Phase 1/2 clinical trial, IGNITE DMD, evaluating lead gene therapy candidate SGT-001 in Duchenne muscular dystrophy (DMD) patients on clinical hold after a participant experienced a serious adverse event related to the study drug.
More news on: Solid Biosciences Inc., Sarepta Therapeutics, Inc., Capricor Therapeutics, Inc., Healthcare stocks news, Stocks on the move,